Pfizer&#39;s Vioxx Problem
29190
NEW YORK - The withdrawal of the arthritis drug Vioxx two weeks ago was a disaster for Merck. But it also put rival Pfizer in a fix.
482981
NEW YORK - Pfizer Inc. said it found an increased risk of heart attacks for patients taking high dosages of its top-selling painkiller Celebrex, the same problem that led to the withdrawal of its one-time competitor Vioxx.
101354
A day after Whitehouse Station-based Merck abruptly withdrew from the market Vioxx, its blockbuster arthritis drug, Pfizer yesterday moved to promote Celebrex, its competing medicine.
499909
Pfizer Inc., the world&#39;s biggest drugmaker, may benefit from Merck &amp; Co.&#39;s withdrawal of Vioxx because Pfizer&#39;s competing pain medicine Celebrex hasn&#39;t been linked to increased risk of heart attacks and strokes.
659174
Many arthritis sufferers who took the drug Vioxx for severe pain are having trouble finding effective treatment alternatives since the drug was taken off the market by its manufacturer, doctors say.
130636
The furor over the safety of arthritis painkilling medications shows no sign of abating. Vioxx is gone from the market, following data linking it to increased cardiovascular risk.
384984
Soon after the anti-arthritis and painkiller drug Vioxx was approved by the Food and Drug Administration in 1999, credible questions surfaced about the risk of serious cardiovascular problems in people who took it.
615822
When Merck&#39;s arthritis drug Vioxx was withdrawn from the market in September, concerns over drug safety were pretty much under the radar for the most part, but not today.
132854
With the recent news of heart problems associated with drugs such as Vioxx, Celebrex and Bextra, people who suffer from the pain associated with arthritis have difficult choices to make.
415864
Arthritis patients who use pain-relief medications similar to Vioxx may have cause for concern. Merck, the maker of Vioxx, pulled it from the market when it said research had found it doubled the risk of heart problems.
496294
The withdrawal of Merck &amp; Co. Inc.&#39;s arthritis drug Vioxx will make it harder for drug companies to win approval for products aimed at big patient populations as regulators
39444
In June 1998, Merck was falling behind in a high-stakes race to get Vioxx on the market ahead of its rivals, and Edward Scolnick, the company&#39;s chief scientist, was showing the strain.
57265
Merck &amp; Co.&#39;s decision to pull its Vioxx anti-arthritis drug from the markets due to severe side effects left pharmaceutical sector mixed Thursday.
323940
First it was antidepressants. Then Vioxx. Now questions have been raised about the safety of yet another drug, the painkiller Bextra, made by Pfizer (PFE ). Is there anything you can do to prevent the unnerving
240439
Pfizer faces big trouble after confirming that Celebrex is linked to heightened cardiac risk. It &quot;can&#39;t win,&quot; says one analyst.
390243
People taking Vioxx may feel betrayed now that the popular painkiller and arthritis medicine has been pulled from the market. Merck, the manufacturer of the drug, and the US Food and Drug Administration knew
497670
Oct. 11 issue - Last week Merck pulled its blockbuster arthritis-and-pain-relief drug Vioxx from the market. This week the 1.27 million Americans who were taking it are wondering what to do.